LOPRESSOR HCT Drug Patent Profile
✉ Email this page to a colleague
When do Lopressor Hct patents expire, and what generic alternatives are available?
Lopressor Hct is a drug marketed by Validus Pharms and is included in one NDA.
The generic ingredient in LOPRESSOR HCT is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
Summary for LOPRESSOR HCT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 135 |
Clinical Trials: | 26 |
Patent Applications: | 3,802 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LOPRESSOR HCT |
What excipients (inactive ingredients) are in LOPRESSOR HCT? | LOPRESSOR HCT excipients list |
DailyMed Link: | LOPRESSOR HCT at DailyMed |
Recent Clinical Trials for LOPRESSOR HCT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Center for Advancing Translational Science (NCATS) | Phase 2 |
University of Wisconsin, Madison | Phase 2 |
Corcept Therapeutics | Phase 1 |
Pharmacology for LOPRESSOR HCT
Drug Class | Thiazide Diuretic beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
Physiological Effect | Increased Diuresis |
Anatomical Therapeutic Chemical (ATC) Classes for LOPRESSOR HCT
US Patents and Regulatory Information for LOPRESSOR HCT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Validus Pharms | LOPRESSOR HCT | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 018303-001 | Dec 31, 1984 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Validus Pharms | LOPRESSOR HCT | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 018303-002 | Dec 31, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Validus Pharms | LOPRESSOR HCT | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 018303-003 | Dec 31, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOPRESSOR HCT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Validus Pharms | LOPRESSOR HCT | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 018303-001 | Dec 31, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | LOPRESSOR HCT | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 018303-003 | Dec 31, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | LOPRESSOR HCT | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 018303-001 | Dec 31, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | LOPRESSOR HCT | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 018303-003 | Dec 31, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOPRESSOR HCT
See the table below for patents covering LOPRESSOR HCT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Switzerland | 578507 | ⤷ Try a Trial | |
Netherlands | 7101885 | ⤷ Try a Trial | |
Japan | S53101322 | PROCESS FOR PREPARING PHENOXYY HYDROXYPROPYLAMINE COMPOUND | ⤷ Try a Trial |
Switzerland | 572896 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LOPRESSOR HCT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0443983 | C00443983/03 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009 |
0565634 | 06C0030 | France | ⤷ Try a Trial | PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607 |
0454511 | 99C0009 | Belgium | ⤷ Try a Trial | PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015 |
0503785 | CA 2011 00026 | Denmark | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |